Research Article
Synovial Sarcoma of the Head and Neck: A Single Institution Review
Table 3
Univariate Cox proportional-hazards model results.
| Variable | PFS | OS | HR (95% CI) | HR (95% CI) |
| Sex | | | Male | 0.52 (0.19–1.47) | 0.90 (0.25–3.20) | Female | | | Race | | | White | 0.65 (0.25–1.71) | 4.97 (0.65–37.83) | Other | | | Tumor size | | | ≥5 cm | 4.69 (1.34–16.38) | 1.17 (0.38–3.58) | <5 cm | | | Subtype | | | Biphasic | 0.72 (0.24–2.15) | 0.097 (0.31–3.07) | Poorly differentiated | 0.55 (0.07–4.33) | 1 (0.12–8.29) | Monophasic | | | Surgical margin | | | Positive | 0.50 (0.60–4.21) | 0.97 (0.11–8.69) | Margin | | | Site | | | Neck | 2.41 (1.00–5.82) | 1.75 (0.64–4.85) | Others | | | Treatment | | | Local + systemic therapy | 1.14 (0.45–2.91) | 1.16 (0.39–3.46) | Definitive local therapy | | |
|
|
PFS: progression-free survival; OS: overall survival; HR: hazard ratio; CI: confidence interval.
|